Intellia Therapeutics Company Profile

Aggregated data from the web about Intellia Therapeutics

Company Name	Intellia Therapeutics
Website	https://www.intelliatx.com
Snippet	Using CRISPR/Cas9 technology, Intellia Therapeutics is developing revolutionary genome editing therapies to cure genetic diseases with simple, targeted treatments.
Type	Public
Founded	2014
Website	intelliatx.com
Industry	Biotherapeutics
Traded as	NASDAQ: NTLA, Russell 2000 Component
Key people	John Leonard (President & CEO), Glenn Goddard (CFO), José Rivera (EVP), Andrew D. Schiermeier (EVP), Laura Sepp-Lorenzino (EVP)
Headquarters	Cambridge, MA, United States

Intellia Therapeutics is part of the United States company list

Have a list of company names and need to update information? Use our Company Search tool.

Please note that Powrbot Inc does not own this content and cannot vouch for its accuracy, we simply aggregate public information for ease of research.

Want to update this profile? Please contact us here with a link to the public source verifying the edit.